Huya Bioscience Japan

Huya Bioscience Japan is owned by Huya Bioscience International. Huya Bioscience International has a direct presence in 3 countries.

View the org chart displaying its 4 main executives

Most searched biographies at Huya Bioscience Japan

• Yukari Hayakawa, Director, Administration
• Hiroshi Onogi, Executive Vice President, Head of Clinical Developm...
• Ken Nanami, Director, Clinical Operations

Create your alert
to follow the executive moves at Huya Bioscience Japan.

Huya Bioscience International has 2,273 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
• Nuvation Bio has announced the acquisition of AnHeart  (posted on April 12 2024).
• D3 Bio has just announced a $62 Million fundraising (posted on April 12 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Huya Bioscience Japan

Social media about Huya Bioscience Japan

• Huya Bioscience Japan on Wikipedia, Google News & Yahoo Finance
• Huya Bioscience Japan on LinkedIn, Twitter & YouTube

Contact by email its executives including Yukari Hayakawa

Call Huya Bioscience Japan at +81 36...

View the org chart

Register to receive your alert

Report an error